Carissa Chu, MD

Title(s)Assistant Professor, Urology
SchoolSchool of Medicine
Address1450 Third Street, #388
San Francisco CA 94158
Phone415-353-7171
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance. Clin Cancer Res. 2023 04 14; 29(8):1377-1380. Aggen DH, Chu CE, Rosenberg JE. PMID: 36749325; PMCID: PMC10106381.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    2. Prostate cancer disparities among American Indians and Alaskan Natives in the United States. J Natl Cancer Inst. 2023 04 11; 115(4):413-420. Chu CE, Leapman MS, Zhao S, Cowan JE, Washington SL, Cooperberg MR. PMID: 36629492; PMCID: PMC10086629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer. Urol Oncol. 2023 Jul; 41(7):326.e1-326.e8. Li KD, Chu CE, Patel M, Meng MV, Morgan TM, Porten SP. PMID: 36868882.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. Cell Rep. 2022 12 20; 41(12):111859. Clinton TN, Chen Z, Wise H, Lenis AT, Chavan S, Donoghue MTA, Almassi N, Chu CE, Dason S, Rao P, Rodrigues JA, Vasani NB, Ridouani F, Rosenberg JE, Bajorin DF, Teo MY, Bochner BH, Berger MF, Ostrovnaya I, Pietzak EJ, Iyer G, Gao SP, Hu W, Al-Ahmadie HA, Solit DB. PMID: 36543146; PMCID: PMC9882421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. Eur Urol Oncol. 2022 12; 5(6):714-718. Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY. PMID: 35216942; PMCID: PMC10262920.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    6. A Cross-Sectional Analysis of Barriers Associated With Non-Attendance at a Urology Telehealth Clinic in a Safety-Net Hospital. Urology. 2022 04; 162:57-62. Bell A, Lonergan PE, Escobar D, Fakunle M, Chu CE, Berdy S, Palmer NR, Breyer BN, Washington SL. PMID: 34461145.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    7. Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin. Clin Cancer Res. 2021 09 15; 27(18):5123-5130. Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J. PMID: 34108177; PMCID: PMC8634828.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    8. Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance. Urology. 2021 09; 155:91-95. de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR. PMID: 34118228.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021 06; 79(6):717-721. Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY. PMID: 33840559.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2021 Jan; 205(1):109-114. Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR. PMID: 33198555.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51. Eur Urol. 2020 09; 78(3):e110-e111. Chu CE, Lonergan PE, Carroll PR. PMID: 32622551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer. Urol Clin North Am. 2020 Feb; 47(1):111-118. Chu CE, Porten SP, Grossfeld GD, Meng MV. PMID: 31757294.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion. Open Forum Infect Dis. 2016 Apr; 3(2):ofw065. Chu CE, Wu F, He X, Zhou K, Cheng Y, Cai W, Geng E, Volberding P, Tucker JD. PMID: 27419150; PMCID: PMC4943171.
      View in: PubMed   Mentions: 5  
    17. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Ultrasound-Guided Renal Access for Percutaneous Nephrolithotomy: A Description of Three Novel Ultrasound-Guided Needle Techniques. J Endourol. 2016 Feb; 30(2):153-8. Chu C, Masic S, Usawachintachit M, Hu W, Yang W, Stoller M, Li J, Chi T. PMID: 26414304; PMCID: PMC4761800.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    19. Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care STDS. 2015 Jul; 29(7):389-99. Lo YR, Chu C, Ananworanich J, Excler JL, Tucker JD. PMID: 26061668; PMCID: PMC4504439.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    20. Trends, utilization, and immediate perioperative complications of urethroplasty in the United States: data from the national inpatient sample 2000-2010. Urology. 2015 May; 85(5):1190-1194. Blaschko SD, Harris CR, Zaid UB, Gaither T, Chu C, Alwaal A, McAninch JW, McCulloch CE, Breyer BN. PMID: 25746579; PMCID: PMC4917203.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    21. Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. AIDS Res Hum Retroviruses. 2015 Jan; 31(1):78-84. Chu CE, Wu F, He X, Ma Q, Cheng Y, Cai W, Volberding P, Tucker JD. PMID: 25427547; PMCID: PMC4287130.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    22. Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. J Pain. 2013 Jul; 14(7):731-8. Ferrari LF, Bogen O, Chu C, Levine JD. PMID: 23664545; PMCID: PMC3700567.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    23. Phosphorylation of Rpt6 regulates synaptic strength in hippocampal neurons. J Neurosci. 2012 Apr 11; 32(15):5126-31. Djakovic SN, Marquez-Lona EM, Jakawich SK, Wright R, Chu C, Sutton MA, Patrick GN. PMID: 22496558; PMCID: PMC3348785.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    24. Generation of a pain memory in the primary afferent nociceptor triggered by PKCε activation of CPEB. J Neurosci. 2012 Feb 08; 32(6):2018-26. Bogen O, Alessandri-Haber N, Chu C, Gear RW, Levine JD. PMID: 22323716; PMCID: PMC3305286.
      View in: PubMed   Mentions: 71     Fields:    Translation:AnimalsCells
    25. Mitochondrial dependence of nerve growth factor-induced mechanical hyperalgesia. Pain. 2011 Aug; 152(8):1832-1837. Chu C, Levine E, Gear RW, Bogen O, Levine JD. PMID: 21570183; PMCID: PMC3161405.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Carissa's Networks
    Concepts (162)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (36)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-1-g3264e86e on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.